Home » Topics » BioWorld Science

BioWorld Science
RSS

Pramlintide shows positive safety/efficacy profile in phase II

Aug. 23, 1996

Humalog launched on U.S. market

Aug. 23, 1996

Hepatitic C infection drug discovery alliance formed

Aug. 23, 1996

Tritec approved for U.S. market

Aug. 23, 1996

McGill University researchers improve safety of cell therapy

Aug. 23, 1996

Bioniche seeks U.S. approval to begin Cystistat clinical trials

Aug. 23, 1996

Boston Scientific to distribute Urologix technology

Aug. 23, 1996

EDAP signs license agreement for microwave technology

Aug. 23, 1996

BTG and the New England Medical Center sign marketing agreement

Aug. 23, 1996

Terumo claims antithrombotic/antiallergy agents

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...